As a pharmaceutical company, we are constantly in discussions with multiple parties on potential collaboration opportunities - in line with our aspiration to drive access and ensure availability of high quality, affordable medicines, says Cipla.
The Exchange had sought clarification from Cipla Ltd with respect to news appearing in ET NOW on February 19, 2015 titled "Cipla plans to acquire Pharma based companies in the US.
"Cipla Ltd clarified "We wish to clarify that Company does not comment on any product or partner discussions. As a pharmaceutical company, we are constantly in discussions with multiple parties on potential collaboration opportunities - in line with our aspiration to drive access and ensure availability of high quality, affordable medicines.
As in the past, the Company would continue to inform stock exchanges about any price sensitive information before the same is made public."
No comments:
Post a Comment